메뉴 건너뛰기




Volumn 7, Issue 3, 2011, Pages 201-206

An Evidence-based Critical Appraisal of a Topic:. Effectiveness of High Dose Donepezil for Advanced Alzheimer's Disease

Author keywords

Alzheimer's disease; Critical appraisal; Donepezil; Evidence based practice; High dose

Indexed keywords


EID: 79952476465     PISSN: 15554155     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurpra.2011.01.018     Document Type: Article
Times cited : (2)

References (10)
  • 1
    • 0348015820 scopus 로고    scopus 로고
    • Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in mild cognitive impairment
    • Tang-Wai DF, Knopman DS, Geda YE, et al. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in mild cognitive impairment. Arch Neurol 2003, 60:1777-1781.
    • (2003) Arch Neurol , vol.60 , pp. 1777-1781
    • Tang-Wai, D.F.1    Knopman, D.S.2    Geda, Y.E.3
  • 3
    • 3242890974 scopus 로고    scopus 로고
    • Donepezil for the symptomatic treatment of patients with middle to moderate Alzheimer's disease: meta-analysis of individual patient data from randomized controlled trials
    • Whitehead A, Perdomo C, Pratt RD, et al. Donepezil for the symptomatic treatment of patients with middle to moderate Alzheimer's disease: meta-analysis of individual patient data from randomized controlled trials. Int J Geriatr Psychiatry 2004, 19:624-633.
    • (2004) Int J Geriatr Psychiatry , vol.19 , pp. 624-633
    • Whitehead, A.1    Perdomo, C.2    Pratt, R.D.3
  • 4
    • 70350673942 scopus 로고    scopus 로고
    • Safety and tolerability of donepezil, rivastigmine, and galantamine for patients with Alzheimer's disease: systematic review of the "real world" evidence
    • Lockhart IA, Mitcheill SA, Kelly S Safety and tolerability of donepezil, rivastigmine, and galantamine for patients with Alzheimer's disease: systematic review of the "real world" evidence. Dement Geriatr Cogn Disord 2009, 28:389-403.
    • (2009) Dement Geriatr Cogn Disord , vol.28 , pp. 389-403
    • Lockhart, I.A.1    Mitcheill, S.A.2    Kelly, S.3
  • 5
    • 41049104686 scopus 로고    scopus 로고
    • Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians
    • Qaseem A, Snow V, Cross T, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008, 148:370-378.
    • (2008) Ann Intern Med , vol.148 , pp. 370-378
    • Qaseem, A.1    Snow, V.2    Cross, T.3
  • 6
    • 77955253242 scopus 로고    scopus 로고
    • Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized double-blind study
    • Farlow MR, Salloway S, Tariot PN, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized double-blind study. Clin Ther 2010, 32(7):1234-1251.
    • (2010) Clin Ther , vol.32 , Issue.7 , pp. 1234-1251
    • Farlow, M.R.1    Salloway, S.2    Tariot, P.N.3
  • 7
    • 17544367627 scopus 로고    scopus 로고
    • Rapid critical appraisal of randomized controlled trials (RCTs): An essential skill for evidence-based practice (EBP)
    • Melynk BM, Fineout-Overholt E Rapid critical appraisal of randomized controlled trials (RCTs): An essential skill for evidence-based practice (EBP). Pediatr Nurs 2005, 31(1):50-52.
    • (2005) Pediatr Nurs , vol.31 , Issue.1 , pp. 50-52
    • Melynk, B.M.1    Fineout-Overholt, E.2
  • 9
    • 70049090749 scopus 로고    scopus 로고
    • A call for the reporting of effect sizes in research reports to enhance critical appraisal and evidence-based practice
    • Mays MZ, Melnyk BM A call for the reporting of effect sizes in research reports to enhance critical appraisal and evidence-based practice. Worldviews Evid Based Nurs 2009, 6(3):125-129.
    • (2009) Worldviews Evid Based Nurs , vol.6 , Issue.3 , pp. 125-129
    • Mays, M.Z.1    Melnyk, B.M.2
  • 10
    • 79952458961 scopus 로고    scopus 로고
    • New dose of Aricept (donepezil): 23 mg
    • New dose of Aricept (donepezil): 23 mg. Pharmacists Letter/Prescribers Letter 2010, 26(9):260905.
    • (2010) Pharmacists Letter/Prescribers Letter , vol.26 , Issue.9 , pp. 260905


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.